Finally, these findings accord with the growing consensus that TNFα, IL-6 and CRP are among the important biomarkers with translational potential in mood disorders, suggesting that this may be true in the psychological as well as pharmacological treatment of depression. The gene discussed is CRP; the disease is depressive symptom measurement.